WO2018004253A3 - 표적 단백질 검출을 위한 압타머-면역세포 바이오프로브 - Google Patents
표적 단백질 검출을 위한 압타머-면역세포 바이오프로브 Download PDFInfo
- Publication number
- WO2018004253A3 WO2018004253A3 PCT/KR2017/006834 KR2017006834W WO2018004253A3 WO 2018004253 A3 WO2018004253 A3 WO 2018004253A3 KR 2017006834 W KR2017006834 W KR 2017006834W WO 2018004253 A3 WO2018004253 A3 WO 2018004253A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bioprobe
- aptamer
- target protein
- immune cell
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/205—Aptamer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4737—C-reactive protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/495—Transforming growth factor [TGF]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
본 발명은 표적 단백질에 특이적으로 결합하는 압타머(aptamer), 및 상기 압타머와 링커(linker)를 통하여 연결된 면역세포를 포함하는 표적 단백질 검출용 바이오프로브(bioprobe)에 관한 것으로서, 단백질을 표적화하는 압타머가 살아있는 면역세포와 결합되어 제조된 실시간으로 체내외 단백질을 검출할 수 있는 바이오프로브를 제공한다. 또한, 상기 바이오프로브를 포함하는 단백질 검출용 진단 시약을 제공한다.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2016-0083261 | 2016-07-01 | ||
KR1020160083261A KR101928620B1 (ko) | 2016-07-01 | 2016-07-01 | 표적 단백질 검출을 위한 압타머-면역세포 바이오프로브 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2018004253A2 WO2018004253A2 (ko) | 2018-01-04 |
WO2018004253A3 true WO2018004253A3 (ko) | 2018-02-22 |
Family
ID=60787370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2017/006834 WO2018004253A2 (ko) | 2016-07-01 | 2017-06-28 | 표적 단백질 검출을 위한 압타머-면역세포 바이오프로브 |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR101928620B1 (ko) |
WO (1) | WO2018004253A2 (ko) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108866063A (zh) * | 2018-06-28 | 2018-11-23 | 中国水产科学研究院珠江水产研究所 | 一种peg修饰的核酸适配体及其制备方法和应用 |
KR102200143B1 (ko) | 2019-01-31 | 2021-01-08 | 한국기술교육대학교 산학협력단 | 표적단백질 검출용 바이오프로브, 이의 제조 방법, 이를 갖는 분석장치 및 그 방법 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060014172A1 (en) * | 2004-05-03 | 2006-01-19 | Nanosphere, Inc. | Aptamer-nanoparticle conjugates and method of use for target analyte detection |
KR101088885B1 (ko) * | 2008-12-23 | 2011-12-07 | 연세대학교 산학협력단 | 바이오프로브, 그 제조방법, 상기를 사용한 분석 장치 및 분석 방법 |
US20110318846A1 (en) * | 2010-06-25 | 2011-12-29 | National Cheng-Kung University | Aptamer and detection method for C-reactive protein |
US20130040837A1 (en) * | 2009-12-01 | 2013-02-14 | Brigham And Women's Hospital, Inc. | Aptamer cell compositions |
US20140017170A1 (en) * | 2008-11-24 | 2014-01-16 | Massachusetts Institute Of Technology | Methods and compositions for localized agent delivery |
-
2016
- 2016-07-01 KR KR1020160083261A patent/KR101928620B1/ko active IP Right Grant
-
2017
- 2017-06-28 WO PCT/KR2017/006834 patent/WO2018004253A2/ko active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060014172A1 (en) * | 2004-05-03 | 2006-01-19 | Nanosphere, Inc. | Aptamer-nanoparticle conjugates and method of use for target analyte detection |
US20140017170A1 (en) * | 2008-11-24 | 2014-01-16 | Massachusetts Institute Of Technology | Methods and compositions for localized agent delivery |
KR101088885B1 (ko) * | 2008-12-23 | 2011-12-07 | 연세대학교 산학협력단 | 바이오프로브, 그 제조방법, 상기를 사용한 분석 장치 및 분석 방법 |
US20130040837A1 (en) * | 2009-12-01 | 2013-02-14 | Brigham And Women's Hospital, Inc. | Aptamer cell compositions |
US20110318846A1 (en) * | 2010-06-25 | 2011-12-29 | National Cheng-Kung University | Aptamer and detection method for C-reactive protein |
Non-Patent Citations (1)
Title |
---|
HWANG, JANGSUN ET AL.: "Aptamer-conjugated Live Human Immune Cell Based Biosensors for the Accurate Detection of C-reactive Protein", SCIENTIFIC REPORTS, vol. 6, 6 October 2016 (2016-10-06), pages 1 - 9, XP055465971 * |
Also Published As
Publication number | Publication date |
---|---|
KR20180004342A (ko) | 2018-01-11 |
KR101928620B1 (ko) | 2018-12-12 |
WO2018004253A2 (ko) | 2018-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1122155T1 (el) | Συζευγμενες ενωσεις που περιλαμβανουν αντισωματα τροποποιημενης κυστεϊνης | |
EA201890285A1 (ru) | Антитела против pd-1, активируемые антитела против pd-1 и способы их применения | |
WO2016210365A3 (en) | Constructs targeting ny-eso-1 peptide/mhc complexes and uses thereof | |
WO2014107599A3 (en) | Compositions and methods for detecting protease activity in biological systems | |
WO2012109624A3 (en) | Monovalent and multivalent multispecific complexes and uses thereof | |
WO2016061286A3 (en) | Compositions of adenosine deaminase-2 (ada2), variants thereof and methods of using same | |
NZ703581A (en) | Anti-cd70 antibody drug conjugates | |
NZ718280A (en) | Antibodies against claudin 18.2 useful in cancer diagnosis | |
MX2018009011A (es) | Anticuerpos anti receptor 1 transmembrana de tirosina-proteina cinasa (ror1) y usos de los mismos. | |
EA201592269A1 (ru) | Способы и композиции для снижения иммуносупрессии опухолевыми клетками | |
EA201891291A1 (ru) | Мультиспецифические антитела | |
EA201101520A1 (ru) | Способы диагностики онкологических заболеваний, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния | |
WO2014183071A3 (en) | In vitro production of red blood cells with sortaggable proteins | |
TN2014000120A1 (en) | Cd27l antigen binding proteins | |
WO2012056457A3 (en) | Compositions and methods for activating expression by a specific endogenous mirna | |
AR092818A1 (es) | Anticuerpo tau humanizado | |
GT201200271A (es) | Proteínas que se unen al tnf-a | |
BR112015011118A2 (pt) | conjugado; composição farmacêutica; e uso de um ou mais dos conjugados | |
IN2014KN02933A (ko) | ||
BR112013009083A2 (pt) | anticorpos humanos de oncostatin m e métodos de uso | |
MY187050A (en) | Cancer cell-specific antibody, anticancer agent, and cancer testing method | |
WO2015013508A3 (en) | Methods for diagnosing and treating immune disease | |
MX358772B (es) | Metodo para detectar cancer. | |
BR112014027905A2 (pt) | anticorpo, célula, ácido nucleico, métodos de identificação de um primeiro anticorpo, de inibição do crescimento de uma célula, de tratamento terapêutico, de determinação da presença de uma proteína, de diagnóstico da presença de um tumor e de distribuição de agente citotóxico. | |
WO2013177593A3 (en) | Identification of mhc class i phospho-peptide antigens from breast cancer utilizing shla technology and complementary enrichment strategies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17820529 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 17820529 Country of ref document: EP Kind code of ref document: A2 |